LYGENT iStrab

Case Western Reserve University, $5,000

LYGENT is developing a novel, easy-to-use ophthalmic screening and diagnostic tool called the iStrab. It will afford providers with a quick, automated assessment of eye misalignment and other vision problems. The iStrab is intended to be an effective aid in clinical treatment and its simplicity and low cost should increase access to appropriate vision care for millions of children across the globe.